These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 1968518)

  • 1. The relative risk of incident coronary heart disease associated with recently stopping the use of beta-blockers.
    Psaty BM; Koepsell TD; Wagner EH; LoGerfo JP; Inui TS
    JAMA; 1990 Mar 23-30; 263(12):1653-7. PubMed ID: 1968518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-blockers and primary prevention of coronary heart disease in patients with high blood pressure.
    Psaty BM; Koepsell TD; LoGerfo JP; Wagner EH; Inui TS
    JAMA; 1989 Apr; 261(14):2087-94. PubMed ID: 2564445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta blockers and the primary prevention of nonfatal myocardial infarction in patients with high blood pressure.
    Psaty BM; Koepsell TD; Wagner EH; LoGerfo JP; Inui TS
    Am J Cardiol; 1990 Nov; 66(16):12G-14G. PubMed ID: 1978545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-adrenergic blocker withdrawal.
    Frishman WH
    Am J Cardiol; 1987 May; 59(13):26F-32F. PubMed ID: 2883874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discontinuation of beta-blockers and the risk of myocardial infarction in the elderly.
    Teichert M; de Smet PA; Hofman A; Witteman JC; Stricker BH
    Drug Saf; 2007; 30(6):541-9. PubMed ID: 17536880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Non arrhythmogenic sudden death as complication of coronary heart disease].
    Zilcher H; Glogar D
    Acta Med Austriaca; 1979; 6(2):59-66. PubMed ID: 42254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Beta-blocker withdrawal syndrome].
    Goliakov VN; Zimin IuV
    Klin Med (Mosk); 1984 Mar; 62(3):15-22. PubMed ID: 6143853
    [No Abstract]   [Full Text] [Related]  

  • 8. Benefits of non-selective versus cardioselective beta-blockers in acute myocardial infarction in hypertensive patients.
    Hansen O; Johansson BW
    J Hypertens Suppl; 1993 Jun; 11(4):S55-60. PubMed ID: 8104242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between cardiovascular outcomes and antihypertensive drug treatment in older women.
    Wassertheil-Smoller S; Psaty B; Greenland P; Oberman A; Kotchen T; Mouton C; Black H; Aragaki A; Trevisan M
    JAMA; 2004 Dec; 292(23):2849-59. PubMed ID: 15598916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of β-blocker therapy with risks of adverse cardiovascular events and deaths in patients with ischemic heart disease undergoing noncardiac surgery: a Danish nationwide cohort study.
    Andersson C; Mérie C; Jørgensen M; Gislason GH; Torp-Pedersen C; Overgaard C; Køber L; Jensen PF; Hlatky MA
    JAMA Intern Med; 2014 Mar; 174(3):336-44. PubMed ID: 24247428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-blockers in hypertensive and coronary heart disease.
    Goldstein S
    Arch Intern Med; 1996 Jun; 156(12):1267-76. PubMed ID: 8651834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Level of blood pressure and risk of myocardial infarction among treated hypertensive patients.
    McCloskey LW; Psaty BM; Koepsell TD; Aagaard GN
    Arch Intern Med; 1992 Mar; 152(3):513-20. PubMed ID: 1347678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-blocker use in ST-segment elevation myocardial infarction in the reperfusion era (GRACE).
    Park KL; Goldberg RJ; Anderson FA; López-Sendón J; Montalescot G; Brieger D; Eagle KA; Wyman A; Gore JM;
    Am J Med; 2014 Jun; 127(6):503-11. PubMed ID: 24561113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence, predictors, and outcomes in treatment-resistant hypertension in patients with coronary disease.
    Bangalore S; Fayyad R; Laskey R; Demicco DA; Deedwania P; Kostis JB; Messerli FH;
    Am J Med; 2014 Jan; 127(1):71-81.e1. PubMed ID: 24210549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The case for beta-blockers as first-line antihypertensive therapy.
    Cruickshank JM
    J Hypertens Suppl; 1992 Jun; 10(3):S21-7. PubMed ID: 1353111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tamoxifen-treated breast carcinoma patients and the risk of acute myocardial infarction and newly-diagnosed angina.
    Bradbury BD; Lash TL; Kaye JA; Jick SS
    Cancer; 2005 Mar; 103(6):1114-21. PubMed ID: 15712362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis Risk in Communities Study.
    Gress TW; Nieto FJ; Shahar E; Wofford MR; Brancati FL
    N Engl J Med; 2000 Mar; 342(13):905-12. PubMed ID: 10738048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Current use of beta-blockers in coronary artery disease].
    Gullestad L; Bjørnerheim R; Offstad J; Endresen K; Forfang K; Kjekshus J; Hansteen V
    Tidsskr Nor Laegeforen; 1999 Jan; 119(1):24-8. PubMed ID: 10025200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Withdrawal phenomena after chronic beta-blockade. Causes and therapeutic consequences].
    Krämer B; Kübler W
    Dtsch Med Wochenschr; 1984 Mar; 109(12):465-71. PubMed ID: 6142815
    [No Abstract]   [Full Text] [Related]  

  • 20. Verapamil-sustained release-based treatment strategy is equivalent to atenolol-based treatment strategy at reducing cardiovascular events in patients with prior myocardial infarction: an INternational VErapamil SR-Trandolapril (INVEST) substudy.
    Bangalore S; Messerli FH; Cohen JD; Bacher PH; Sleight P; Mancia G; Kowey P; Zhou Q; Champion A; Pepine CJ;
    Am Heart J; 2008 Aug; 156(2):241-7. PubMed ID: 18657652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.